Over the past decade, significant regulatory reforms have been implemented in order to make derivatives markets safer and more robust. A major test of these reforms came in the first half of 2020, as the COVID-19 pandemic disrupted global financial markets and central banks intervened to provide much-needed liquidity.
While derivatives experienced volatility and liquidity pressures in line with cash markets, they continued to function without any major issues or dislocations reported by policy-makers or market participants.
The performance of derivatives markets during the pandemic reflects important changes and a significant reduction in counterparty credit risk over the past decade. As a result of the financial regulatory reforms, derivatives markets have become safer, more resilient and more transparent.
Documents (1) for Evolution of OTC Derivatives Markets Since the Financial Crisis
Latest
Episode 59: Reducing Burdens
As she nears the end of her term as chair of the European Securities and Markets Authority, Verena Ross joins The Swap to discuss progress in simplifying and reducing the burden of EU financial regulation, including transaction reporting. Please view...
CDS Market Dynamics: Record 2025
Global credit default swap (CDS) market activity reached a record $41.8 trillion in 2025, surpassing the previous peak of $38.7 trillion in 2022. Index CDS drove the increase, accounting for 93.3% of total activity and reaching a record $39.0 trillion....
ISDA Letter to CFTC on Public Interest Determinations for Event Contracts
On July 27, ISDA submitted a letter to the U.S. Commodity Futures Trading Commission (CFTC) on the CFTC’s proposed rulemaking on public interest determinations for event contracts published in the Federal Register on June 12, 2026. ISDA emphasized the importance...
ISDA Letter to BCBS on RMA Models
On July 24, ISDA wrote to the Basel Committee on Banking Supervision (BCBS) to request guidance on how the proposed Risk Mitigation Accounting (RMA) model under International Financial Reporting Standard (IFRS) 9/IFRS 7 should be treated for prudential regulatory capital...